Northwest Biotherapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2012
Total Assets: $7.6M
Liabilities Breakdown FY2012
Total Liabilities: $12.6M
Asset Breakdown
Total Assets: $7.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.3M | 97.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $95.0K | 1.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $129.0K | 1.7% |
Liabilities Breakdown
Total Liabilities: $12.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.2M | 64.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $4.5M | 35.3% |